Sirtinol promotes PEPCK1 degradation and inhibits gluconeogenesis by inhibiting deacetylase SIRT2
Abstract Phosphoenolpyruvate carboxykinase 1 (PEPCK1) is the critical enzyme for gluconeogenesis and is linked with type II diabetes. Previous studies have found that SIRT2, a deacetylase, plays an important role in deacetylating PEPCK1 and little is known about the anti-diabetic activity of SIRT2 i...
Enregistré dans:
Auteurs principaux: | Mingming Zhang, Yida Pan, Robert G. Dorfman, Yuyao Yin, Qian Zhou, Shan Huang, Jie Liu, Shimin Zhao |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Nature Portfolio
2017
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/ed6b75e32b7c475a94c7c22d11ce7103 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Author Correction: Pyrophosphate inhibits gluconeogenesis by restricting UDP-glucose formation in vivo
par: Ali Ferjani, et autres
Publié: (2019) -
Circ-SIRT1 inhibits cardiac hypertrophy via activating SIRT1 to promote autophagy
par: Weichen Wang, et autres
Publié: (2021) -
O-GlcNAcylation of SIRT1 enhances its deacetylase activity and promotes cytoprotection under stress
par: Cuifang Han, et autres
Publié: (2017) -
Sirtinol treatment reduces inflammation in human dermal microvascular endothelial cells.
par: Angela Orecchia, et autres
Publié: (2011) -
Histone deacetylase 11 inhibition promotes breast cancer metastasis from lymph nodes
par: Patrick L. Leslie, et autres
Publié: (2019)